Trace Amine-Associated Receptor 1 Modulates Dopaminergic Activity

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2008-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.107.132647PMID 18083911
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia

  2007influential reference
• Glutamatergic neurons are present in the rat ventral tegmental area

  2007cited by this paper
• A region of 35 kb containing the trace amine associate receptor 6 (TAAR6) gene is associated with schizophrenia in the Irish study of high-density schizophrenia families

  2007cited by this paper
• Hyperdopaminergia and altered locomotor activity in GABAB1‐deficient mice

  2006cited by this paper
• A second class of chemosensory receptors in the olfactory epithelium

  2006cited by this paper
• Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors.

  2005influential reference
• A renaissance in trace amines inspired by a novel GPCR family.

  2005influential reference
• Dopamine transporter‐dependent and ‐independent actions of trace amine β‐phenylethylamine

  2004cited by this paper
• Brain substrates for increased drug seeking during protracted withdrawal.

  2004cited by this paper
• Anatomic and Functional Topography of the Dorsal Raphe Nucleus

  2004cited by this paper
• Inhibitory effects of trace amines on rat midbrain dopaminergic neurons.

  2004influential reference
• Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators

  2004influential reference
• The rhinal cortices: a wall of inhibition between the neocortex and the hippocampus.

  2004cited by this paper
• The amygdala and appraisal processes: stimulus and response complexity as an organizing factor.

  2004cited by this paper
• Sleep-promoting functions of the hypothalamic median preoptic nucleus: inhibition of arousal systems.

  2004cited by this paper
• Enhancement of the NMDA receptor function by reduction of glycine transporter-1 expression.

  2004influential reference
• Basolateral Amygdala Interacts with Other Brain Regions in Regulating Glucocorticoid Effects on Different Memory Functions

  2004cited by this paper
• Presynaptic regulation of dopaminergic neurotransmission

  2003cited by this paper
• Cerebrospinal fluid monoamine and metabolite concentrations and aggression in rats.

  2003cited by this paper
• Depression and antisocial personality disorder: two contrasting disorders of 5HT function.

  2003cited by this paper
• Trace amine receptors as targets for novel therapeutics: legend, myth and fact.

  2003cited by this paper
• Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety.

  2003cited by this paper
• Development of SHIRPA to characterise the phenotype of gene-targeted mice.

  2001cited by this paper
• A genome screen for genes predisposing to bipolar affective disorder detects a new susceptibility locus on 8q.

  2001cited by this paper
• Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

  2001cited by this paper
• Trace amines: Identification of a family of mammalian G protein-coupled receptors

  2001influential reference
• Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1.

  2000cited by this paper
• A cortical–hippocampal system for declarative memory

  2000cited by this paper
• G-protein mediated gating of inward-rectifier K+ channels.

  2000cited by this paper
• Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.

  2000cited by this paper
• Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees.

  1997cited by this paper
• Substance Abuse: A Comprehensive Textbook

  1992cited by this paper
• Comparative effects of amphetamine, phenylethylamine and related drugs on dopamine efflux, dopamine uptake and mazindol binding.

  1988cited by this paper
• Analysis of Trace Amines: Endogenous Levels and the Effects of Various Drugs on Tissue Concentrations in the Rat

  1984cited by this paper
• A short amino acid sequence able to specify nuclear location.

  1984cited by this paper
• Phenylethylamine and brain function.

  1978cited by this paper
• Studies on dopamine uptake and release in synaptosomes.

  1978cited by this paper
• Octopamine as a putative neurotransmitter.

  1976cited by this paper
• Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse

  1968cited by this paper

• Novel selective morpholine trace amine-associated receptor 1 partial agonists show promising preclinical effects for neuropsychiatric disorders and are well tolerated in healthy volunteers.

  2026cites this paper
• Functional implications of the C182F TAAR1 variant identified in patients with schizophrenia

  2026cites this paper
• TAAR1 activation normalizes dopamine signaling and decreases alcohol intake in SRKO mice after adolescent ethanol exposure.

  2026cites this paper
• TAAR1-mediated pathways regulating nigrostriatal function and the discovery and pharmacological characterization of a novel TAAR1 agonist, Selutaront

  2026cites this paper
• Mechanisms of Parkinsonism Development and Novel Approaches to Multisystem Neurorehabilitation

  2025cites this paper
• Small Fibre Pathology in Fibromyalgia: A review

  2025cites this paper
• Role of Glial Trace Amine Associated Receptor 1 (TAAR1) and Microbiota in Schizophrenia

  2025cites this paper
• Trace amine signaling in zebrafish models: CNS pharmacology, behavioral regulation and translational relevance.

  2025cites this paper
• Preclinical development of [18F]TAAR1-2203 as a PET radioligand for imaging TAAR1 expression and receptor occupancy

  2025cites this paper
• The Neurometabolic Function of the Dopamine–Aminotransferase System

  2025cites this paper
• Absence of TAAR1 function increases methamphetamine-induced excitability of dorsal raphe serotonin neurons and drives binge-level methamphetamine intake

  2025cites this paper
• Comparison of Dopamine and Tyramine Action on the Firing Rate of Trigeminal Dural Afferents in Wild Type and DAT-HET Rats

  2025cites this paper
• New Insights into Complex PTSD Treatment: Focus on TAAR1 Agonists

  2025cites this paper
• Rational Design of the First Dual Agonist at Trace Amine-Associated Receptor 1 and 5-HT2C Receptors Based on Binding Pocket Similarity for the Treatment of Schizophrenia and Alzheimer's Disease-Related Psychosis.

  2025cites this paper
• GPCR Heterodimers: Implications for Biased Signaling.

  2025cites this paper
• Trace Amines and Their Receptors: Historical Context and Contribution of Genetic Models to Research

  2025cites this paper
• Trace amine receptor in GtoPdb v.2025.3

  2025cites this paper
• Perinatal methimazole exposure impairs the distribution and function of layer 5 neurons in the mouse auditory cortex

  2025cites this paper
• Trace amine–associated receptor 1 agonists differentially regulate dopamine transporter function

  2025cites this paper
• Trace amine-associated receptors (TAARs)2-9 knockout mice exhibit reduced wakefulness and disrupted REM sleep

  2025cites this paper
• A quantitative analysis of TAAR1-positive cells in whole mouse brain by FDISCO technology.

  2025cites this paper
• The trace amine-associated receptor 1 regulates presynaptic dopamine function: evidence from preclinical studies and a phase 1b trial in patients with schizophrenia.

  2025cites this paper
• Trace amine-associated receptor 1 (TAAR1) activation reduced mania-relevant hyperexploration and risky decision-making in dopamine transporter knockdown mice

  2025cites this paper
• Trace Amine-Associated Receptor 1 agonists reduce alcohol drinking and differentially modulate dopamine release in the nucleus accumbens of alcohol preferring mice.

  2025cites this paper
• Trace Amine-Associated Receptors’ Role in Immune System Functions

  2024cites this paper
• Computational Methods for the Discovery and Optimization of TAAR1 and TAAR5 Ligands

  2024cites this paper
• TAAR2-9 Knockout Mice Exhibit Reduced Wakefulness and Disrupted REM Sleep

  2024cites this paper
• Activation of trace amine-associated receptor 1 ameliorates PTSD-like symptoms.

  2024cites this paper
• Trace amine associated receptor 1: predicted effects of single nucleotide variants on structure-function in geographically diverse populations

  2024cites this paper
• Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular Modeling

  2024cites this paper
• The trace amine-associated receptor 1 agonists – non-dopaminergic antipsychotics or covert modulators of D2 receptors?

  2024cites this paper
• Behavioral pharmacology of mescaline - the role of serotonin 5-HT2A, 5-HT2B, 5-HT2C and 5-HT1A receptors

  2024cites this paper
• SEP‐363856 exerts neuroprotection through the PI3K/AKT/GSK‐3β signaling pathway in a dual‐hit neurodevelopmental model of schizophrenia‐like mice

  2024cites this paper
• TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding

  2024cites this paper
• New drug treatments for schizophrenia: a review of approaches to target circuit dysfunction.

  2024cites this paper
• TAAR1 as a new target for the treatment of bipolar disorder: Anti-manic and anti-depressant activity of the novel agonist PCC0105004

  2024cites this paper
• Trace amine-associated receptor 1 (TAAR1): an emerging therapeutic target for neurodegenerative, neurodevelopmental, and neurotraumatic disorders

  2024cites this paper
• Modulators of the Brain Serotonin System in Rats with Genetically Determined Aggression towards Man or Its Absence

  2024cites this paper
• Mescaline-induced behavioral alterations are mediated by 5-HT2A and 5-HT2C receptors in rats.

  2024cites this paper
• Plasma metabolomic characteristics of atrial fibrillation patients with spontaneous echo contrast

  2024cites this paper
• Molecular Mechanisms of Methamphetamine-Induced Addiction via TAAR1 Activation

  2024cites this paper
• Unlocking the secrets of trace amine-associated receptor 1 agonists: new horizon in neuropsychiatric treatment

  2024cites this paper
• Ligands of the trace amine-associated receptors (TAARs): A new class of anxiolytics.

  2024cites this paper
• A review of amphetamine extended release once-daily options for the management of attention-deficit hyperactivity disorder

  2024cites this paper
• Wakefulness Induced by TAAR1 Partial Agonism in Mice Is Mediated Through Dopaminergic Neurotransmission

  2024influential citation
• Beyond dopamine: Novel strategies for schizophrenia treatment

  2024cites this paper
• Wakefulness Induced by TAAR1 Partial Agonism is Mediated Through Dopaminergic Neurotransmission

  2024influential citation
• TAAR1 as an emerging target for the treatment of psychiatric disorders.

  2023cites this paper
• Robust aversive effects of trace amine-associated receptor 1 activation in mice

  2023cites this paper
• Protein Metabolism Changes and Alterations in Behavior of Trace Amine-Associated Receptor 1 Knockout Mice Fed a High-Fructose Diet

  2023cites this paper
• Neural mechanism of acute stress regulation by trace aminergic signalling in the lateral habenula in male mice

  2023cites this paper
• Trace amine receptor in GtoPdb v.2023.1

  2023cites this paper
• Expression Pattern of Trace Amine-Associated Receptors during Differentiation of Human Pluripotent Stem Cells to Dopaminergic Neurons

  2023cites this paper
• Recognition of methamphetamine and other amines by trace amine receptor TAAR1

  2023cites this paper
• Nongenomic roles of thyroid hormones and their derivatives in adult brain: are these compounds putative neurotransmitters?

  2023cites this paper
• Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatments.

  2023cites this paper
• Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia

  2023cites this paper
• Up-regulation of the Trace Amine Receptor, TAAR-1, in the Prefrontal Cortex of Individuals Affected by Schizophrenia.

  2023cites this paper
• T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line

  2023cites this paper
• Modeling Parkinson’s disease in LRRK2 rodents

  2023cites this paper
• Trace Amine-Associated Receptor 1 Agonists for Schizophrenia

  2022cites this paper
• Identification of a Potent Human Trace Amine-Associated Receptor 1 Antagonist.

  2022cites this paper
• Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines

  2022cites this paper
• Chemogenetic Enhancement of cAMP Signaling Renders Hippocampal Synaptic Plasticity Resilient to the Impact of Acute Sleep Deprivation

  2022cites this paper
• Modelling of p-tyramine transport across human intestinal epithelial cells predicts the presence of additional transporters

  2022cites this paper
• Fibromyalgia Pathophysiology

  2022cites this paper
• TAAR1 dependent and independent actions of the potential antipsychotic and dual TAAR1/5-HT1A receptor agonist SEP-363856

  2022cites this paper
• Improved Cognitive Performances in Trace Amine-Associated Receptor 5 (TAAR5) Knock-out Mice

  2022cites this paper
• Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders.

  2022influential citation
• Trace amine-associated receptor 1 modulates motor hyperactivity, cognition, and anxiety-like behavior in an animal model of ADHD.

  2022cites this paper
• TAAR1 regulates drug-induced reinstatement of cocaine-seeking via negatively modulating CaMKIIα activity in the NAc

  2022cites this paper
• Natural Sympathomimetic Drugs: From Pharmacology to Toxicology

  2022cites this paper
• Discovery of Novel Trace Amine-Associated Receptor 5 (TAAR5) Antagonists Using a Deep Convolutional Neural Network

  2022cites this paper
• Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer’s Disease

  2022cites this paper
• Enhancer Regulation of Dopaminergic Neurochemical Transmission in the Striatum

  2022cites this paper
• Phenethylamine is a substrate of monoamine oxidase B in the paraventricular thalamic nucleus

  2022cites this paper
• Stimulus Specific Adaptation Is Affected in Trace Amine-Associated Receptor 1 (TAAR1) Knockout Mice

  2022cites this paper
• Sensory Gating in TAAR1 Knockout Mice

  2022cites this paper
• Improved cognitive performance in trace amine-associated receptor 5 (TAAR5) knock-out mice

  2022cites this paper
• Present and future antipsychotic drugs: a systematic review of the putative mechanisms of action for efficacy and a critical appraisal under a translational perspective.

  2022cites this paper
• Activation of trace amine-associated receptor 1 (TAAR1) reduces alcohol drinking behaviors in mice

  2022cites this paper
• Activation of trace amine-associated receptor 1 (TAAR1) transiently reduces alcohol drinking in socially housed mice

  2022cites this paper
• Trace amine-associated receptor 1 and drug abuse.

  2022cites this paper
• Trace Amine-Associated Receptor 2 Is Expressed in the Limbic Brain Areas and Is Involved in Dopamine Regulation and Adult Neurogenesis

  2022cites this paper
• Pharmacological characterization of 3,4-methylenedioxamphetamine (MDA) analogs and two amphetamine-based compounds: N,α-DEPEA and DPIA.

  2022cites this paper
• Trace amine-associated receptor 1 (TAAR1) agonists

  2022cites this paper
• Class A and C GPCR Dimers in Neurodegenerative Diseases

  2022cites this paper
• Impact of Nitisinone on the Cerebrospinal Fluid Metabolome of a Murine Model of Alkaptonuria

  2022cites this paper
• Effects of acute and chronic administration of trace amine-associated receptor 1 (TAAR1) ligands on in vivo excitability of central monoamine-secreting neurons in rats

  2022cites this paper
• Binding of SEP-363856 within TAAR1 and the 5HT1A receptor: implications for the design of novel antipsychotic drugs

  2021cites this paper
• Confirmation of a Causal Taar1 Allelic Variant in Addiction-Relevant Methamphetamine Behaviors

  2021cites this paper
• Trace Amine-Associated Receptor 1 Contributes to Diverse Functional Actions of O-Phenyl-Iodotyramine in Mice but Not to the Effects of Monoamine-Based Antidepressants

  2021cites this paper
• The dual orexin receptor antagonist almorexant blocks the sleep-disrupting and daytime stimulant effects of methamphetamine in rhesus monkeys.

  2021cites this paper
• Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions

  2021cites this paper
• The selective TAAR1 partial agonist RO5263397 promoted novelty recognition memory in mice

  2021cites this paper
• Population pharmacokinetic analysis of ulotaront in subjects with schizophrenia

  2021cites this paper
• Trace Amine-Associated Receptor 1 Trafficking to Cilia of Thyroid Epithelial Cells

  2021cites this paper
• Role of the Trace Amine Associated Receptors 5 (TAAR5) in Sensorimotor Functions

  2021cites this paper
• Map-independent representation of an aggression-promoting social cue in the main olfactory pathway

  2021cites this paper
• Thiourea assisted recyclization of 1-(chloromethyl)dihydroisoquinolines: a convenient route to β-(o-thiazolylaryl)ethylamines

  2021cites this paper